middle.news
AdAlta Secures $1.1M to Propel CAR-T and Immunotherapy Advances
9:47am on Tuesday 3rd of June, 2025 AEST
•
Biotechnology
Read Story
AdAlta Secures $1.1M to Propel CAR-T and Immunotherapy Advances
9:47am on Tuesday 3rd of June, 2025 AEST
Key Points
Raised $1.1 million via renounceable rights issue
Issued over 363 million new shares and 181 million options
Funds to advance CAR-T licensing and business development for AD-214 and WD-34
Directors and CEO fully participated, signaling strong confidence
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Adalta (ASX:1AD)
OPEN ARTICLE